Alfasigma gains arthritis drug, access to new markets with M&A play

Alfasigma gains arthritis drug, access to new markets with M&A play

Alfasigma acquires Nordic Pharma, adding rheumatology portfolio (Nordimet methotrexate) with Japan, Canada market access. Follows M&A-focused playbook: external expansion in rare disease and immunology builds global specialty presence through targeted consolidation.